Northern Michigan University and Micro Imaging Technology to Collaborate on Rapid Detection of Staph and MRSA Pathogens
October 25 2013 - 8:00AM
Marketwired
Northern Michigan University and Micro Imaging Technology to
Collaborate on Rapid Detection of Staph and MRSA Pathogens
SAN CLEMENTE, CA--(Marketwired - Oct 25, 2013) - Micro
Imaging Technology, Inc. (OTCQB: MMTC) announced today that it will
collaborate with the Northern Michigan University (NMU) Department
of Biology to expand MIT's technology to identify and differentiate
Staphylococcus aureus (S. aureus) and Methicillin
Resistant Staphylococcus aureus (MRSA). The
goal of the strategic research with NMU is to rapidly and
cost-effectively identify these two particular healthcare threats
using the MIT 1000 System, a bacterial cell based identification
system that can identify pathogenic bacteria in three minutes
(average) at significant cost savings per test.
At this stage the collaboration involves scientists from MIT and
NMU gathering preliminary data and developing collaborative
research proposals seeking funding in support of continued
research.
Dr. Josh S. Sharp, Ph.D., assistant professor at the Northern
Michigan University Department of Biology, will direct the NMU
portion of the research at his laboratory in Marquette,
MI. Sharp received a B.S. at Western Michigan University in
1998 and his Ph.D. in Biological Sciences at the Mount Sinai School
of Medicine of New York University in 2006. His initial
research in this collaboration will focus on clinical applications
of the MIT 1000.
"Being able to quickly identify if a patient has an S.
aureus infection, and whether or not that S. aureus
is MRSA, a strain of S. aureus resistant to certain
antibiotics would be extremely useful in dictating the proper
course of treatment for that patient, and ultimately increase the
likelihood of a successful patient outcome," Sharp said.
Micro Imaging Technology's Chief Scientist, Dr. David Haavig, is
the program director of the effort and will lead MIT's team in the
collaboration. He received his Ph.D. in Physics from Purdue
University in 1983. Haavig was instrumental in developing the MIT
1000, a stand-alone, rapid laser based bacteria detection and
identification technology that can detect pathogenic bacteria and
complete an identifying test in less than three minutes (average)
at significant cost savings per test.
"We are extremely pleased to be working with Dr. Sharp and his
staff on this project," Haavig said. "We are confident that
this collaborative effort will be highly successful and the result
of our teamwork and the clinical implications for this technology
may very well prove to be immeasurable."
About: Northern Michigan University
Northern Michigan University, located in Marquette, Michigan, is
a dynamic four-year, public, coeducational university that has
grown its reputation based on its award-winning leadership
programs, cutting-edge technology initiatives and nationally
recognized academic programs. The university's fastest growing
academic areas are clinical science, biology, and the geographical
and environmental sciences. Northern Michigan has a population
of about 9,200 undergraduate and graduate students. It offers 180
degree programs, including 18 graduate programs.
About: Micro Imaging Technology, Inc.
Micro Imaging Technology, Inc. is a California-based public
company that is also registered to do business under the name
Micro Identification Technologies. MIT has developed
and patented the MIT 1000, a stand-alone, rapid, optically-based,
software driven system that can identify pathogenic bacteria and
complete an identification test, after culturing, in three minutes
(average) at the lowest cost per test when compared to any other
conventional method. It does not rely on chemical or biological
agents, conventional processing, fluorescent tags, gas
chromatography or DNA analysis. The process requires only
clean filtered water and a sample of the unknown
bacteria. Revenues for all rapid testing methods exceed $5
billion annually -- with food safety accounting for more than $3.5
billion, which is expected to surpass $4.7 billion by 2015
according to BCC Research. In addition, the recently passed "New"
U.S. Food Safety Bill is expected to further accelerate the current
annual growth rate of 6.6 percent.
In June 2009, the AOAC Research Institute (AOAC RI) awarded the
Company Performance Tested Methods SM (PTM) certification for the
rapid identification of Listeria. The AOAC RI provides an
independent third party evaluation and expert reviews of methods
and will award PTM certification to methods that demonstrate
performance levels equivalent or better than other certified
bacteria identifying methods. The MIT System underwent hundreds of
individual tests, including ruggedness and accuracy, to earn AOAC
RI's certification for the identification of Listeria.
You can find more information about our company and about Micro
Identification Technologies™. Please visit our newly enhanced
website at www.micro-identification.com.
This release contains statements that are forward-looking in
nature. Statements that are predictive in nature, that depend
upon or refer to future events or conditions or that include words
such as "expects," "anticipates," "intends," "plans," "believes,"
"estimates," and similar expressions are forward-looking
statements. These statements are made based upon information
available to the Company as of the date of this release, and we
assume no obligation to update any such forward-looking statements.
These statements are not guarantees of future performance and
actual results could differ materially from our current
expectations. Factors that could cause or contribute to such
differences include, but are not limited to dependence on
suppliers; short product life cycles and reductions in unit selling
prices; delays in development or shipment of new products; lack of
market acceptance of our new products or services; inability to
continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and
other factors and risks associated with our business are discussed
from time to time within our filings with the Securities and
Exchange Commission, reference MMTC: www.sec.gov.
CONTACT: Jeffrey Nunez President and CEO Email: Email Contact
Web Site: www.micro-imaging.com Telephone: (949) 388-4546
Micro Imaging Technology (CE) (USOTC:MMTC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Micro Imaging Technology (CE) (USOTC:MMTC)
Historical Stock Chart
From Nov 2023 to Nov 2024
